Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact.

Vargas AC, Lakhani SR, Simpson PT.

Future Oncol. 2009 Mar;5(2):233-43. doi: 10.2217/14796694.5.2.233. Review.

PMID:
19284381
2.

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas.

Simpson PT, Reis-Filho JS, Lambros MB, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Dexter T, Jones A, Reid L, Da Silva L, Shin SJ, Hardisson D, Ashworth A, Schmitt FC, Palacios J, Lakhani SR.

J Pathol. 2008 Jul;215(3):231-44. doi: 10.1002/path.2358.

PMID:
18473330
3.

Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ.

Shin SJ, Lal A, De Vries S, Suzuki J, Roy R, Hwang ES, Schnitt SJ, Waldman FM, Chen YY.

Hum Pathol. 2013 Oct;44(10):1998-2009. doi: 10.1016/j.humpath.2013.04.004. Epub 2013 Jun 25.

PMID:
23809857
4.

Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity.

Reis-Filho JS, Simpson PT, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Valgeirsson H, Lambros M, Ashworth A, Palacios J, Schmitt F, Lakhani SR.

J Pathol. 2005 Sep;207(1):1-13.

PMID:
15957152
5.
6.

Pleomorphic lobular carcinoma of the breast: a morphologically and clinically distinct variant of lobular carcinoma.

Butler D, Rosa M.

Arch Pathol Lab Med. 2013 Nov;137(11):1688-92. doi: 10.5858/arpa.2012-0603-RS. Review.

PMID:
24168512
7.

Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.

Palacios J, Sarrió D, García-Macias MC, Bryant B, Sobel ME, Merino MJ.

Mod Pathol. 2003 Jul;16(7):674-8.

8.

Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast.

Chen YY, Hwang ES, Roy R, DeVries S, Anderson J, Wa C, Fitzgibbons PL, Jacobs TW, MacGrogan G, Peterse H, Vincent-Salomon A, Tokuyasu T, Schnitt SJ, Waldman FM.

Am J Surg Pathol. 2009 Nov;33(11):1683-94. doi: 10.1097/PAS.0b013e3181b18a89.

9.

Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis.

Middleton LP, Palacios DM, Bryant BR, Krebs P, Otis CN, Merino MJ.

Am J Surg Pathol. 2000 Dec;24(12):1650-6.

PMID:
11117786
10.

Lobular carcinoma, not only a classic.

Brogi E, Murray MP, Corben AD.

Breast J. 2010 Sep-Oct;16 Suppl 1:S10-4. doi: 10.1111/j.1524-4741.2010.00994.x.

PMID:
21050299
11.

Invasive pleomorphic lobular carcinoma, negative for ER, PR and Her/2neu--a case report.

Manucha V, Khilko N, Reilly K, Zhang X.

Int J Clin Exp Pathol. 2011 Jan 30;4(2):200-5.

12.

Pleomorphic lobular carcinoma: a distinctive clinical and molecular breast cancer type.

Monhollen L, Morrison C, Ademuyiwa FO, Chandrasekhar R, Khoury T.

Histopathology. 2012 Sep;61(3):365-77. doi: 10.1111/j.1365-2559.2012.04230.x. Epub 2012 Apr 4.

PMID:
22486370
13.

The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.

Weigelt B, Geyer FC, Natrajan R, Lopez-Garcia MA, Ahmad AS, Savage K, Kreike B, Reis-Filho JS.

J Pathol. 2010 Jan;220(1):45-57. doi: 10.1002/path.2629.

PMID:
19877120
14.

E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.

Wahed A, Connelly J, Reese T.

Ann Diagn Pathol. 2002 Dec;6(6):349-51.

PMID:
12478484
16.

Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.

Chivukula M, Haynik DM, Brufsky A, Carter G, Dabbs DJ.

Am J Surg Pathol. 2008 Nov;32(11):1721-6. doi: 10.1097/PAS.0b013e31817dc3a6.

PMID:
18769331
17.

Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes.

Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, Schubert EL, Holcomb IN, Massa HF, Glogovac J, Li CI, Malone KE, Daling JR, Delrow JJ, Trask BJ, Hsu L, Porter PL.

Cancer Res. 2004 Dec 1;64(23):8541-9.

18.
19.

E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.

Mastracci TL, Tjan S, Bane AL, O'Malley FP, Andrulis IL.

Mod Pathol. 2005 Jun;18(6):741-51.

20.

Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.

Fadare O, Dadmanesh F, Alvarado-Cabrero I, Snyder R, Stephen Mitchell J, Tot T, Wang SA, Ghofrani M, Eusebi V, Martel M, Tavassoli FA.

Am J Surg Pathol. 2006 Nov;30(11):1445-53.

PMID:
17063087

Supplemental Content

Support Center